Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)
Stephen L. Abrams (Creator)
Shaw M. Akula (Creator)
Fulvio Barbaro (Creator)
Lucio Cocco (Creator)
Przemyslaw Duda (Creator)
Richard A. Franklin (Creator)
Agnieszka Gizak (Creator)
Michelle M. LaHair (Creator)
Alberto M. Martelli (Creator)
James A. McCubrey (Creator)
Akshaya K. Meher (Creator)
Stefano Ratti (Creator)
Linda S. Steelman (Creator)
Institution
East Carolina University (ECU )
Web Site: http://www.ecu.edu/lib/

Additional Information

Publication
Other
Language: English
Date: 2023
Subjects
TP53;pancreatic cancer;drug sensitivity

Email this document to

This item references:

TitleLocation & LinkType of Relationship
Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Propertieshttp://hdl.handle.net/10342/11681The described resource references, cites, or otherwise points to the related resource.